Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000086105 | SCV003440389 | pathogenic | not provided | 2023-03-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 82 of the BEST1 protein (p.Leu82Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant Best macular dystrophy (PMID: 10394929, 19357557, 20375334). ClinVar contains an entry for this variant (Variation ID: 99696). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function. Experimental studies have shown that this missense change affects BEST1 function (PMID: 21878505). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. |
Retina International | RCV000086105 | SCV000118249 | not provided | not provided | no assertion provided | not provided | ||
Clinical Genetics, |
RCV000086105 | SCV001924327 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000086105 | SCV001954156 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000086105 | SCV001970680 | pathogenic | not provided | no assertion criteria provided | clinical testing |